A new strategic phase for genomic medicine in UK health services

In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled that the use of genomic medicine was at a crossroads, due to the rapid development of new tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Hilary, Wright, Caroline F, Zimmern, Ron
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784306/
https://www.ncbi.nlm.nih.gov/pubmed/19822024
http://dx.doi.org/10.1186/gm93
Descripción
Sumario:In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled that the use of genomic medicine was at a crossroads, due to the rapid development of new technologies, and opened up opportunities across the whole of medicine and healthcare. This commentary responds to the report's call for a new health service strategy, including a new genetics White Paper from the Government, and suggests some of the important elements that need further consideration.

Ejemplares similares